ADXN
Addex Therapeutics Ltd
NASDAQ · Healthcare · Biotechnology · CH
$3.69
−0.54%Leverage
- Debt / equity
- 0.03x
- Net debt / equity
- -0.25x
- Debt / assets
- 0.02x
- Debt / EBITDA
- -0.01x
- Net debt / EBITDA
- 0.12x
Liquidity & coverage
- Current ratio
- 0.97x
- Quick ratio
- 0.97x
- Cash ratio
- 0.77x
- Interest coverage
- -543.94x
- EBITDA / interest
- —
- Working capital
- -$40.3K
Cash & dividend
- FCF / debt
- -22.76x
- Cash flow / debt
- -22.76x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Mar 1, 2026